Tender detail
Non-exclusive rebate agreement for lidocaine-containing medicines
Summary
The tender concerns the conclusion of a non-exclusive rebate agreement for medicines containing lidocaine for the period 1 September 2026 to 31 August 2028, with an option to extend the contract once by 12 months. It concerns the supply of medicines for DAK-Gesundheit and may be open to as many interested pharmaceutical companies as possible.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.